ARCHIVES

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Where’s The Money for Local Programs? Everyone Wants To Know

February 28, 1975

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

Cancer Patient Medical history System Proposed

July 13, 1979

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001

HHS Draft of Bill Reauthorizing NIH Specifically Kills Bypass Budget, Would End National Cancer Act of 1971

March 29, 1985